Jean George
CIK 1291804 · last filed 2024-02-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$615.4K
Companies
8
Total Filings
43
Lifetime Open-Market Net
-$34.38M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Cyteir Therapeutics, Inc. (CYT) Delisted | Director | 2,458,415 | $3.02 | $7.42M | $0 | 4 | 2024-02-16 |
| Calithera Biosciences, Inc. (CALA) Delisted | Director | 90,504 | $0.00 | $27 | $3.00M | 8 | 2021-06-14 |
| ALXO | 10%+ Owner | 309,222 | $1.99 | $615.4K | $68.40M | 1 | 2020-07-22 |
| ACCELERON PHARMA INC (XLRN) Delisted | Director | 5,127 | $178.75 | $916.5K | -$57.46M | 15 | 2020-01-24 |
| Astria Therapeutics, Inc. (CATB) Delisted | Director | 90,764 | $8.54 | $775.1K | $3.11M | 4 | 2018-06-07 |
| Zeltiq Aesthetics Inc (ZLTQ) Delisted | Director | 5,786 | — | — | -$51.43M | 9 | 2015-07-23 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Director | 27,939 | — | — | $0 | 1 | 2013-05-30 |
| CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | Director | — | $1.95 | — | $0 | 1 | 2007-05-03 |
Recent Filings · Page 5 of 5
43 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-05-30 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Conv (C) | +1,543,280 | $0 | EDGAR |
| 2012-06-18 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-05-03 | CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 41–43 of 43
Prev
Page 5 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.